The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

Camille N. Kotton, Deepali Kumar, Angela M. Caliendo, Shirish Huprikar, Sunwen Chou, Lara Danziger-Isakov, Atul Humar

Research output: Contribution to journalArticle

183 Scopus citations

Abstract

Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients, conveying higher risks of complications, graft loss, morbidity, and mortality. Research in the field and development of prior consensus guidelines supported by The Transplantation Society has allowed a more standardized approach to CMV management. An international multidisciplinary panel of experts was convened to expand and revise evidence and expert opinion-based consensus guidelines on CMV management including prevention, treatment, diagnostics, immunology, drug resistance, and pediatric issues. Highlights include advances in molecular and immunologic diagnostics, improved understanding of diagnostic thresholds, optimized methods of prevention, advances in the use of novel antiviral therapies and certain immunosuppressive agents, and more savvy approaches to treatment resistant/refractory disease. The following report summarizes the updated recommendations.

Original languageEnglish (US)
Pages (from-to)900-931
Number of pages32
JournalTransplantation
Volume102
Issue number6
DOIs
StatePublished - Jun 1 2018

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation'. Together they form a unique fingerprint.

  • Cite this